Hsbc Holdings PLC Ligand Pharmaceuticals Inc Transaction History

Hsbc Holdings PLC

$168 Billion
Q4 2024

A detailed history of Hsbc Holdings PLC transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Hsbc Holdings PLC holds 3,764 shares of LGND stock, worth $407,076. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,764

Previous 3,159 19.15%

Holding current value

$407,076

Previous $316,000 27.53%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$99.95 - $129.9 $60,469 - $78,589	605 Added 19.15%	3,764 $403,000
Q3 2024 Nov 14, 2024	SELL	$82.7 - $110.11 $122,561 - $163,183	-1,482 Reduced 31.93%	3,159 $316,000
Q2 2024 Aug 12, 2024	SELL	$68.53 - $87.91 $41,323 - $53,009	-603 Reduced 11.5%	4,641 $391,000
Q1 2024 May 15, 2024	BUY	$68.64 - $89.2 $359,948 - $467,764	5,244 New	5,244 $383,000
Q2 2023 Aug 11, 2023	SELL	$69.53 - $79.33 $3,059 - $3,490	-44 Reduced 1.1%	3,949 $284,000
Q1 2023 May 15, 2023	BUY	$65.67 - $77.08 $262,220 - $307,780	3,993 New	3,993 $293,000
Q3 2022 Nov 14, 2022	SELL	$0.01 - $107.56 $11 - $118,316	-1,100 Reduced 30.29%	2,532 $226,000
Q2 2022 Aug 11, 2022	SELL	$74.52 - $117.06 $29,957 - $47,058	-402 Reduced 9.97%	3,632 $324,000
Q1 2022 May 16, 2022	BUY	$94.99 - $151.56 $258,372 - $412,243	2,720 Added 207.0%	4,034 $461,000
Q4 2021 Feb 11, 2022	BUY	$127.69 - $165.85 $167,784 - $217,926	1,314 New	1,314 $202,000
Q4 2020 Feb 12, 2021	SELL	$80.55 - $106.05 $397,433 - $523,250	-4,934 Closed	0 $0
Q3 2020 Nov 12, 2020	SELL	$89.56 - $126.72 $517,656 - $732,441	-5,780 Reduced 53.95%	4,934 $478,000
Q2 2020 Aug 14, 2020	BUY	$68.28 - $123.65 $258,644 - $468,386	3,788 Added 54.69%	10,714 $1.2 Million
Q1 2020 May 15, 2020	BUY	$63.37 - $107.88 $315,836 - $537,673	4,984 Added 256.64%	6,926 $498,000
Q4 2019 Feb 14, 2020	SELL	$96.94 - $113.59 $292,274 - $342,473	-3,015 Reduced 60.82%	1,942 $205,000
Q3 2019 Nov 14, 2019	SELL	$86.25 - $120.16 $1.88 Million - $2.62 Million	-21,835 Reduced 81.5%	4,957 $493,000
Q2 2019 Aug 13, 2019	SELL	$107.38 - $129.34 $3.84 Million - $4.63 Million	-35,772 Reduced 57.18%	26,792 $3.06 Million
Q1 2019 May 15, 2019	BUY	$105.93 - $142.47 $2.32 Million - $3.12 Million	21,870 Added 53.74%	62,564 $7.87 Million
Q4 2018 Feb 13, 2019	BUY	$128.36 - $272.13 $3.93 Million - $8.33 Million	30,604 Added 303.31%	40,694 $5.52 Million
Q3 2018 Nov 13, 2018	BUY	$211.18 - $274.49 $361,962 - $470,475	1,714 Added 20.46%	10,090 $2.77 Million
Q2 2018 Aug 10, 2018	SELL	$150.77 - $207.98 $1.67 Million - $2.31 Million	-11,101 Reduced 57.0%	8,376 $1.74 Million
Q1 2018 May 11, 2018	SELL	$138.63 - $182.62 $2.07 Million - $2.73 Million	-14,929 Reduced 43.39%	19,477 $3.22 Million
Q4 2017 Feb 14, 2018	BUY	$128.36 - $147.04 $45,952 - $52,640	358 Added 1.05%	34,406 $4.71 Million
Q3 2017 Nov 14, 2017	SELL	$120.91 - $137.94 $1.12 Million - $1.28 Million	-9,296 Reduced 21.45%	34,048 $4.64 Million
Q2 2017 Aug 14, 2017	BUY	N/A	43,344	43,344 $5.26 Million

Others Institutions Holding LGND

# of Institutions

277

Shares Held

18.5M

Call Options Held

30.8K

Put Options Held

5.2K

View Full List

About LIGAND PHARMACEUTICALS INC

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $1.83B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

More about LGND

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

News

Stay updated on Hsbc Holdings PLC with notifications on news.

Account

Hsbc Holdings PLC Ligand Pharmaceuticals Inc Transaction History